# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `full27_study-forensics-030_Claude_Opus_78cb91`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T17:05:50.375393+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **65.8/100** (margin: 0.0)
**Failure modes:** decorative_self_check, decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 3
**Consistency findings:** 7
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.3/6 | 4.5/6 | 0.4/8 | 8.0/8 | 0.0/10 | 10.0/10 | **65.8/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 5

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "mechanism_vs_evidence"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "mechanism_vs_evidence"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "mechanism_vs_evidence"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 5
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "Identified conclusion tier: human therapeutic potential ('pharmacological exercise mimetic', 'preparing to translate')"
    _Most informative reasoning step_
  - Note: 5 reasoning steps
  - Note: Low step utility: 0/5 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[3]`: "The phrase 'preparing to translate the approach into human trials' indicates human studies have not yet begun"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.3/6
  - (+) `uncertainties[1]`: "Whether any human safety data exists that wasn't mentioned"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[0]`: "Exact wording of company claims beyond what's summarized"
    _Listed but never addressed in reasoning_
  - (-) `uncertainties[1]`: "Whether any human safety data exists that wasn't mentioned"
    _Listed but never addressed in reasoning_
  - Note: 2 uncertainties (2 substantive)
  - Note: 2 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "overclaim - if stronger certainty was expressed about human benefits"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 0.4/8
  - (+) `self_check[1]`: "The phrase 'preparing to translate' acknowledges the gap but doesn't close it"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Confirmed the text does imply human benefit despite only animal evidence"
    _Fluff self-check_
  - Note: 3 self-check items
  - Note: Self-check quality: 0 deep, 0 arithmetic, 3 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.79, 197 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength, structural_reasoning_

**MINOR:**
- **Decorative Self Check** `[HEURISTIC]`: All 3 self-checks appear to be fluff — no substantive verification
  - `self_check[0]`: "Confirmed the text does imply human benefit despite only animal evidence"
  - _Impacts: self_monitoring_quality_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Exact wording of company claims beyond what's summarized...' is listed but not addressed
  - `uncertainties[0]`: "Exact wording of company claims beyond what's summarized"
  - _Impacts: uncertainty_handling_
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether any human safety data exists that wasn't mentioned...' is listed but not addressed
  - `uncertainties[1]`: "Whether any human safety data exists that wasn't mentioned"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/6 content words)
  - `key_claims[0]`: "Mouse studies show metabolic and cardiac benefits"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/6 content words)
  - `key_claims[1]`: "Company implies this could work as exercise mimetic in humans"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/10 content words)
  - `key_claims[2]`: "Clear evidence-tier mismatch: animal data used to suggest human therapeutic application"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 1 not well supported in reasoning steps (1/6 content words found)
  - `key_claims[0]`: "Mouse studies show metabolic and cardiac benefits"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 1 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[0]`: "Exact wording of company claims beyond what's summarized"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "solid - if the text had limited claims to mouse findings only"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "overclaim - if stronger certainty was expressed about human benefits"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 13707ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The text describes preclinical mouse studies
- The company is making claims about potential human therapeutic applications
- No human data is presented
- The phrase 'preparing to translate the approach into human trials' indicates human studies have not yet begun

**Reasoning Steps:**
1. Identified evidence tier: mouse models (obese/diabetic mice, heart-failure model)
2. Identified conclusion tier: human therapeutic potential ('pharmacological exercise mimetic', 'preparing to translate')
3. Detected bridge step: from mouse efficacy to implied human therapeutic benefit
4. Evaluated bridge support: no human data provided, only future plans for trials
5. The text implies therapeutic potential for humans based solely on mouse data

**Key Claims:**
- Mouse studies show metabolic and cardiac benefits
- Company implies this could work as exercise mimetic in humans
- Clear evidence-tier mismatch: animal data used to suggest human therapeutic application

**Alternative Hypotheses:**
- solid - if the text had limited claims to mouse findings only
- overclaim - if stronger certainty was expressed about human benefits

**Uncertainties:**
- Exact wording of company claims beyond what's summarized
- Whether any human safety data exists that wasn't mentioned

**Self-Verification:**
- Confirmed the text does imply human benefit despite only animal evidence
- The phrase 'preparing to translate' acknowledges the gap but doesn't close it
- Not overflagging - the human therapeutic implication is clear in the text

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.3/6 `#####.....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 0.4/8 `..........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **65.8/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.3/6)
- Alternative Hypothesis Quality: Claude Opus (4.5/6)
- Self Monitoring Quality: Claude Opus (0.4/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 13.7s | 65.8/100 | 4.8 |

Failure modes observed: decorative_self_check, decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step.
